PROGRAMS OF DOH

COMMUNICABLE DISEASES
GROUP-4A
National TB Control
Program
BY: RECTO, LOISA
 DESCRIPTION
1. Tuberculosis is an infectious disease that primarily affects the lungs and this condition is known
as pulmonary tuberculosis
2. Extra-pulmonary tuberculosis
VISION
 TB- free Philippines
MISSION
1. To reduce TB burden (TB incidence and TB mortality)
2. To achieve catastrophic cost of TB-affected household
3. To responsively deliver TB service
PROGRAM COMPONENTS
 Health Promotion
Financing and Policy
Human Resource
Information System
Regulation
Service Delivery
Governance
TARGET POPULATION/CLIENT

Presumptive TB and TB affected households

AREA OF COVERAGE
•Nationwide
VI. Partner Institutions

Department of Health: Food and Drug Administration, Bureau of Quarantine

Other Government: DepEd, DSWD, DILG (BJMP), DOJ (BuCor), PIA, DOLE
Non Government Organizations: PhilCAT, PBSP
International Organizations: WHO, USAID, GFATM, ICRC, HIVOS-KNCV

VII. Policies and Laws

RA 10767 : Comprehensive TB Elimination Plan Act of 2016

VIII. Strategies, Action Points and Timeline

2017-2022 Philippine Strategic TB Elimination Plan

Activate communities and patient groups to promptly access quality TB services

Collaborate with other government agencies to reduce out-of-pocket expenses and expand
social protection programs
Harmonize local and national efforts mobilize adequate and competent human resources
Innovate TB information generation and utilization for decision making
Enforce standards on TB care and prevention and use of quality products
Value clients and patients through integrated patient-centered TB services
Engage national, regional and local government units/ agencies on multi-sectoral
implementation of TB elimination plan
IX. Program Accomplishments and Status

2019 WHO Global TB Report (Cohort of 2018)

Estimate TB Burden : Mortality 24/100,000 Incidence 554/100,000

Total Notified Cases: 382,543
Treatment Coverage: 63%
Treatment Success Rate, All Forms (2017) : 91%
Treatment Success Rate, MDR/RRTB (2016) 58%
 NATIONAL LEPROSY
CONTROL
PROGRAM
- R O X A S , LY K A R AY PA U L I N E A .
DESCRIPTION
The National Leprosy Control Program (NLCP) is a multi-agency effort to control
Leprosy in the country with private and public partnership in achieving its goals
to lessen the burden of the disease and its mission to have a leprosy-free
country.
 VMO
VISION
Leprosy-free Philippines by the year 2022
MISSION
To ensure the provision of comprehensive, integrated quality leprosy services at all levels of
healthcare
OBJECTIVES
•To further reduce the disease burden and sustain provision of high-quality leprosy services for
all affected communities ensuring that the principle of equity and social justice are followed
•To decrease by 50% the identified hyper endemic cities and municipalities
PROGRAM COMPONENTS

Early diagnosis and treatment

Integration of leprosy services
Referral system
Case detection and diagnosis
Advocacy and IEC focusing on stigma discrimination and reduction
Prevention of Deformity, self-care and rehabilitation
Recording and reporting
Monitoring, supervision and evaluation
PARTNER INSTITUTIONS

World Health Organization

Novartis Foundation
Sasakawa Memorial Health Foundation
Culion Foundation, Inc.
Philippine Leprosy Mission
Cebu Leprosy and TB Research Foundation Inc.
Philippine Dermatological Society
Coalition of Leprosy Advocates and Patients in the Philippines
International Leprosy Association
 POLICIES AND LAWS
Administrative Order No. 167, s. 1965: Rules and Regulations of Leprosy Control in the Philippines

Republic Act No. 4073: An Act further liberalizing the treatment of leprosy by amending and repealing certain
sections of the revised Administrative Code

Presidential Decree No. 384 January 30, 1974: Amending Republic Act No. 4073 entitled An Act further liberalizing
the treatment of leprosy by amending and repealing certain sections of the revised Administrative Code

Proclamation No. 467: Declaring the Last Week of February of every year as Leprosy Week

Administrative Order No. 26 – A, s. 1997: Guidelines on Elimination of Leprosy as Public Health Problem

Administrative Order No. 5, s. 2000: Guidelines on the integration of leprosy services in hospitals

Department memorandum No. 79, s. 2004: Recommendations to pursue Leprosy Elimination Activities in all areas
in the country

Department Circular 366-B, s. 2003: First Leprosy Forum of the Philippine Dermatological Society on November 12,
2003

Department Circular 254, s. 2004: Second Leprosy Forum of the Philippine Dermatological Society on November 9,
2004
STRATEGIES, ACTION POINTS AND TIMELINE

Strengthen local government ownership, coordination and partnership

Ensuring political commitment and adequate resources for leprosy programs at all levels
Contributing to UHC with a special focus on children, women and underserved populations
including migrants and displaced people.
Promoting partnerships with state and non-state actors and promote inter-sectoral
collaboration and partnerships at the international, national and sub-national level  
Facilitating and conducting basic and operational research in all aspects of leprosy and
maximize the evidence base to inform policies, strategies and activities.
Strengthening surveillance and health information systems for program monitoring and
evaluation (including geographical information systems)
Stop leprosy and its complications

Strengthening patient education and community awareness on leprosy.

Promoting early case detection through active case-finding (e.g. campaigns) in areas of higher
endemicity and contact management.
Ensuring prompt start and adherence to treatment, including working towards improved
treatment regimens
Improving and management of disabilities.
 Strengthening surveillance for antimicrobial resistance including laboratory network.
Promoting innovative approaches for training, referrals and sustaining expertise in leprosy such
e-Health (LEARNS)
Promoting interventions for the prevention of infection and disease. -Chemoprophylaxis
Stop discrimination and promote inclusion

Promoting societal inclusion through addressing all forms of discrimination and stigma
Empowering persons affected by leprosy and strengthen their capacity to participate actively in
leprosy services. -CLAP
Involving communities in actions for improvement of leprosy services.
Promoting coalition-building among persons affected by leprosy and encourage the integration
of these coalitions and or their members with other CBOs.
 Promoting access to social and financial support services, e.g. to facilitate income generation,
for persons affected by leprosy and their families.
Supporting community-based rehabilitation for people with leprosy related disabilities
PROGRAM ACCOMPLISHMENTS/STATUS

 
 
Indicators
2017
 

   

Prevalence rate of <1 per 10,000 population 0.4

 
 
MB/PB (new cases)
1660/249
 

 
 
Children below 15 years old & proportion
6.7%
 
The National Leprosy Control Program in coordination with the Research Institute for Tropical
Medicine (RITM) has started the National Leprosy Baseline Survey this year (2018) and expected
to be completed in 2019. This will help the program in prioritizing augmentation in areas with
high prevalence rate. This will also give a real picture of the country’s status in maintaining the
elimination level of leprosy cases.
Continuous support has been given to all new MB and PB cases through provision of supportive
drugs from the NLCP and Multidrug Therapy (MDT) from World Health Organization (WHO).
CALENDAR OF ACTIVITIES
World Leprosy Day (Every last Sunday of January)
Leprosy Control Week (Every 4th week of February)
National Skin Disease Detection and Prevention Week (Every 2nd week  of November)
STATISTICS
STATISTICS
PROGRAM MANAGER CONTACT INFORMATION

Dr. Julie Mart C. Rubite

National Program Manager for Leprosy Control Program
Disease Prevention and Control Bureau
Contact No.: 651-7800 local 2354, 2350, 2354
Email Address: nlcp.doh@gmail.com
 FOOD AND WATERBORNE
DISEASES PREVENTION
AND CONTROL PROGRAM
-ROXAS, LRP
DESCRIPTION

FWBDs refer to the limited group of illnesses characterized by diarrhea, nausea, vomiting with
or without fever, abdominal pain, headache and/or body malaise. These are spread or acquired
through the ingestion of food or water contaminated by disease-causing microorganisms
(bacterial or its toxins, parasitic, viral).
V-M-O
VISION
◦ Zero Mortality from FWBDs

MISSION
◦ To reduce morbidity and mortality due to FWBDs

OBJECTIVES
To guarantee universal access to quality FWBD-PCP intervention and services at all stages of the
life
To guarantee financial risk protection of clients availing diagnosis, management and treatment for
FWBDs
To guarantee a responsive service delivery network for the prevention and control of FWBDs
 PROGRAM COMPONENTS

A. Policy, Plans and Organizational Support.

B. Diagnosis, Management and Treatment.
C. Quality Assurance System.
D. Logistic Management.
E. Capability Building.
F. Health Promotion and Advocacy.
G. Monitoring and Evaluation, Research, Surveillance and Response.
H. Outbreak Response/Disaster Management.
TARGET POPULATION/ CLIENT
◦ FWBD by Sex
◦ FWBDs by Age Group
◦ FWBDs by Geographical Areas

PARTNER INSTITUTIONS
A. Department of Health – Central Office
1. Infectious Disease Office (IDO) - Disease Prevention and Control Bureau (DPCPB)
2. Environmental Health and Sanitation
3. Epidemiology Bureau (EB)
4. Health Emergency Management Bureau (HEMB)
5. Health Promotion and Communication Services (HPCS)
6. Research Institute for Tropical Medicine (RITM) and National Reference Laboratories (Parasitology, Bacterial Enterics
and Viral Enterics)
7. Food and Drug Administration (FDA)
B. DOH – Regional Offices
1. Infectious Disease Prevention and Control Cluster
2. Regional Epidemiology and Surveillance Unit (RESU)
3. Environmental and Occupational Health Unit
4. Provincial DOH Office
C. Other Government Agencies
1. Department of Interior and Local Government (DILG)
2. Department of Education
3. Department of Agriculture
4. Department of Social Welfare and Development
5. Department of Environment and Natural Resources
D. Local Government Units (LGUs)
E. Hospitals
F. Laboratories
1. Subnational Laboratories
2. Regional Laboratories
3. Tertiary Hospitals
4. Level 3 Laboratories
5. Level 2 Laboratories
6. Level 1 Laboratories
7. Rural Health Units
STRATEGIES, ACTION POINTS, AND TIMELINE

Strategy 1. Regulate and monitor food and water sanitation practices at the local level through
enforcement of national and local legislations, application of appropriate technical standards and
participation of non-government agencies.
Strategy 2. Sustain inter-agency collaboration to fast-track sanitation infrastructure development in
poor urban areas and in rural areas with low access to safe water and sanitation facilities.
Strategy 3. Promote personal hygiene, food and water sanitation practices and the principles of
environmental health.
Strategy 4. Promote the use of ORS in the management of diarrhea to prevent dehydration, especially
among infants and children.
Strategy 5. Promote breastfeeding and other good feeding practices for infants and children.
Strategy 6. Continue training of health personnel in the early diagnosis and treatment of food-borne and
waterborne diseases.
Strategy 7. Continue nationwide information campaign for the prevention and control of food-borne
and waterborne diseases
 National Rabies
Control Program
By: Salcedo, Sigrid Joy.
DESCRIPTION
Rabies is a human infection that occurs after a transdermal bite or scratch by an infected
animal.
Can be transmitted via saliva
Rabies may also occur, though in very rare cases
it is one of the most acutely fatal infection and it is responsible for the death of 200-300
Filipinos annually
VISION
To declare Philippines Rabies-Free by year 2022

MISSION
To eliminate human rabies by the year 2020
OBJECTIVES
To eliminate rabies as a public health problem
PROGRAM COMPONENTS
Post and Pre Exposure Prophylaxis
Health Education and advocacy campaign
Training/Capability Building
Training on National Rabies Information System (NaRIS)
DOH-DA joint evaluation and declaration of Rabies-free areas/provinces
PARTNER INSTITUTIONS
Department of Agriculture (DA)
Department of Education (DepEd)
Department of Interior and Local Government (DILG)
Department of Environment and Natural Resources
(DENR)
World Health Organization (WHO)
Animal Welfare Coalition (AWC)
PROGRAM
ACCOMPLISHMENTS/STATUS
 NATIONAL STD/HIV AIDS

HIV, AIDS AND STI PREVENTION AND

CONTROL PROGRAM
By: Serania, Abegail
Vision
To achieve ZERO new infections, ZERO discrimination, and ZERO AIDS-
related death.

Mission
To improve access and utilization of preventive primary health care
services for HIV and STI,
Goals
To reverse the trend of HIV epidemic by reducing the estimated
annual infections to less than 7,000 cases by 2022.

Objective
Reduce the transmission of HIV and STI among the Most At
Risk Population and General Population and mitigate its impact at
the individual, family, and community level.
Types of Service
PhilHealth Benefit Package
Philhealth Circular 011-2015 & 2018-0004: Outpatient HIV and AIDS Treatment (OHAT)
Package

Trainings
HIV Counseling and Testing Training
Primary HIV Care Training for health service providers 
Program Activities
1. Availability of free voluntary HIV Counseling and Testing Service;
2. 100% Condom Use Program (CUP) especially for entertainment establishments;
3.  Peer education and outreach;
4.  Multi-sectoral coordination through Philippine National AIDS Council (PNAC);
5.  Empowerment of communities;
6. Community assemblies and for a to reduce stigma;
7.  Augmentation of resources of social Hygiene Clinics; and
8. Procured male condoms distributed as education materials during outreach.
Partner Organizations/Agencies
National/Government
All members of the Philippine National AIDS Council
DepEd
DOLE
DSWD
DILG
CSC
CHED
NYC
PIA
DBM
Chair, Senate Committee on Health & Demography
Chair, House of Representative Committee on Health
PLHIV Organizations (Pinoy Plus Advocacy Pilipinas, Inc,. & Project Red Ribbon)
NGO Representatives (Action for Health Initiative, Alagad-Mindanao, Positive Action Foundation
Philippines Inc., AIDS Society of the Philippines, The Library Foundation Share Collective)

Local/Youth/CSOs/NGOs
Pilipinas Shell Foundation, Inc.
The LoveYourself
Sustained Health Initiatives of the Philippines
Lakan Champion Community Center
HIV and AIDS Support House
Y-Peer Pilipinas
International Partners

WHO
UN (UNAIDS, UNFPA, UNICEF, UNODC)
Family Health International
USAID
“KNOCK-OUT TIGDAS" (KOT) 2007
FA Q S

-Serania
 • “Knock-out Tigdas 2007” is a sequel to
the 1998 and 2004 “Ligtas Tigdas” mass
measles immunization campaign. All
W H AT I S children 9 months to 48 months old 
should be vaccinated against measles.
“KNOCK-OUT
TIGDAS (KOT)
• This is the second follow-up measles
2007? campaign to eliminate measles infection
as a public health problem.
W H AT I S T H E O V E R - A L L
OBJECTIVE OF THE
KNOCK-OUT TIGDAS?

• The Knock-out Tigdas is a strategy to reduce the

number or pool of children at risk of getting measles
or being susceptible to measles and achieve 95%
measles immunization coverage. Ultimately, the
objective of KOT is to eliminate measles circulation
in all communities by 2008.
W H A T D O E S M E A S L E S E L I M I N AT I O N
MEAN?
• Measles elimination means:

1. Less than one (1) measles case is confirmed measles per one million population.

2. Detects and extracts blood for laboratory confirmation from at least 2 suspect measles
cases per 100,000 populations.

3. No secondary transmission of measles. This means that when a measles case occurs,
measles is not transmitted to others.
W H O S H O U L D B E VA C C I N A T E D ?

• All children between 9 months to 48 months old ( born October 1, 2003 – January
1,2007) should be vaccinated against measles.

WHEN WILL IT BE DONE?

Immunization among these children will be done on October 15-

November 15, 2007.
HOW WILL IT BE DONE?

• Vaccination teams go from door-to-door of every house or every building in search of

the targeted children who needs to be vaccinated with a dose of measles vaccines,
Vitamin A capsule and deworming drug.

• All health centers, barangay health stations, hospitals and other temporary
immunization sites such as basketball court, town plazas and other identified public
places will also offer FREE vaccination services during the campaign period.
M Y C H I L D H A S B E E N VA C C I N AT E D A G A I N S T
MEASLES. IS SHE EXEMPTED FROM THIS
VA C C I N AT I O N C A M PA I G N ?

• No, she is not. A previously vaccinated child is not exempted from the vaccination
campaign because we cannot be sure if her previous vaccination was 100% effective.

• Chances are a vaccinated child is already protected, but no one can really be sure.
There is 15% vaccine failure when the vaccine is given to 9 months old children. We
want to be 100% sure of their protection.
W H AT S T R A T E G Y W I L L B E U S E D D U R I N G
T H E C A M PA I G N ?
• It is a door-to-door strategy. The team goes from one-household to another in all areas
nationwide.

M Y C H I L D H A D M E A S L E S P R E V I O U S L Y,
I S H E E X E M P T E D I N T H I S C A M PA I G N ?  
• There are many measles-like diseases. We cannot be sure exactly what the child had,
especially if the illness occurred years ago. Anyway, the vaccination will not harm a
child who already had measles. The effect will also be like a booster vaccination. The
previously received measles immunization has formed antibodies, with the booster
shot it will strengthened the said antibodies.
IS THERE ANY OVERDOSE, IF MY CHILD
R E C E I V E S T H I S B O O S T E R I M M U N I Z AT I O N ?

• Antibodies in the blood which provide protection against disease decrease as the child
grows older. Booster vaccinations are needed to raise protection again. Measles
vaccination during the said campaign will be a booster vaccination for a previously
vaccinated child. The child’s waning internal protection will increase. The child will
not harm because there is no vaccine overdose for the measles vaccine. The measles
vaccine is even known to enhance overall immunity against other diseases.
W H AT W I L L H A P P E N T O M Y C H I L D
AFTER RECEIVING THE MEASLES
I M M U N I Z AT I O N ?
• Normally, the child will have slight fever. The fever is a sign that the child’s vaccine
is working and is helping the body develop antibodies against measles.

• The best thing to do when the child has fever is to give him paracetamol every four
(4) hours. Give him plenty of fluids and breastfeed the child. Ensure that the child has
enough rest and sleep.
W H AT W I L L H A P P E N A F T E R T H E “ K N O C K -
OUT TIGDAS 2007”?

• To interrupt measles circulation by 2008, ALL children ages 9 months will continue to
routinely receive one dose of the measles vaccine together with the vaccines the other
disease of the childhood like polio, diphtheria, pertussis, etc. All children with fever
and rashes have to be listed and tested to verify the cause of the infection.

• ALL 18 months old children will be given a second dose of measles immunization to
really ensure that these children are protected against measles infection.
 W H AT O T H E R S E R V I C E S W I L L B E G I V E N ?

• Vitamin A capsule will be given to all children 6 months to 71 month old and
deworming tablet to 12 months to 71 months old nationwide.

ADDITIONAL MESSAGES:
• Once the child is vaccinated, the posterior upper left earlobe will be marked with
gentian violet, so do not try to remove for the purpose of validation.
• Houses will also be marked, so do not erase.
• “I heard that there are cases where the child who was vaccinated who became
seriously ill or died. Is this true?
• Measles vaccine is very safe. Minor reactions may occur such as fever but in an
already immunizes child, this may not occur. The most serious and RARE adverse
event following immunization is anaphylaxis which is inherent on the child, not on the
vaccines.
National Schistosomiasis Control and
Elimination Program
-Sulong
 Schistosomiasis
is an acute and chronic disease caused by parasitic worms called trematodes or blood
flukes.
It is transmitted through contact with fresh water infested with the cercarial
schistosome of the parasite that penetrates human skin.
Vision:
Schistosomiasis Free Philippines
Mission:
Synchronized and harmonized public and private stakeholders’ efforts in the
elimination of schistosomiasis in the Philippines
Objectives
Interruption of transmission of Schistosomiasis Infection by 2025:

1. All high endemic barangays will reach the target of criteria for Morbidity/Infection
Control
2. All moderate endemic barangays will reach the target of criteria of Transmission
Control
3. All low endemic barangays will reach the target criteria of Transmission
Interruption
Types of Service:
Trainings
Training on the Clinical Practice Guidelines for the Diagnosis, Treatment and
Prevention of Schistosoma Japonicum infections in the Philippines
The Department of Health (DOH) strengthened the
Schistosomiasis Control and Elimination Program:

Preventive Chemotherapy
Intensified Case Management
Water, Sanitation and Hygiene (WASH)
Veterinary Public Health and the Promotion of Animal Health under One
Health Approach
Effective Intermediate Host Control and Surveillance
Partner Organizations:

National/Government
Department of Education
National Irrigation Administration
Bureau of Animal Industry, Department of Agriculture
Department of Interior and Local Government (DILG)  
Public Information Agency (PIA)
Kapisanan ng mga Broadkaster ng Pilipinas (KBP)
Department of Environment and Natural Resources (DENR)
Local Government Units (LGUs)
International Partners
Research Triangle Institute (RTI) International
World Health Organization (WHO)
AEDES-BORNE VIRAL
DISEASES PREVENTION
AND CONTROL
PROGRAM
-TAGAPULOT
AEDES-BORNE VIRAL DISEASES PREVENTION
AND CONTROL PROGRAM
The prevalence of aedes-borne viral diseases such as dengue is still a significant problem that the country
faces as it affects many Filipinos that can lead to severe complications and even death. Aside from the
dengue, other aedes-borne viral diseases, such as zika and chikungunya, are also controlled to eradicate their
transmissions. This program, aims to expand and integrate the existing program to include the prevention and 
control interventions for various aedes-borne viral diseases such as dengue, zika, and chikungunya, and other
diseases with similar vectors.

Vision
Aedes-borne Viral Disease-free Philippines

Mission
Reduced disease burden of Dengue, containment and prevention of transmission of Chikungunya and
Zika
Goals:
To reduce the disease burden of dengue, and to contain and prevent transmission of chikungunya
and zika

Types of Service
PhilHealth Benefit Package

Selected Medical Case Rates – Additional Implementing Guidelines

Trainings

• Dengue Clinical Case Management and Program Management

• Nucleic Acid Amplification Test-Loop Mediated Isothermal Assay (NAAT-LAMP) Training as One of
Dengue Confirmatory Tests of the National Aedes-borne Prevention and Control Program (NDPCP)
• National Dengue Death / Mortality Review
Partner Organization:
International Health Partner:
• World Health Organization through Special Service Agreement and Short Term Consultants
Clinical Management
• Philippine Society for Microbiology and Infectious Diseases, Inc.
• Pediatric Infectious Disease Society of the Philippines
Diagnostic and Entomology
• Research Institute for Tropical Medicine
FILARIASIS ELIMINATION
PROGRAM
• The Elimination started in 2001 after a pilot study using the combination drugs in 2000 in five selected
municipalities in five provinces.
• Total no. of province: 81
• Total population in the country: 103, 741, 330 as of 2018
• Total Endemic Provinces: 46 Provinces in 12 Regions
• Total Endemic Population: 8 Million
• Parasite: Majority is Wuchereria bancrofti
• Vectors incriminated: Aedes poecilius, Anopheles flavirostris

Vision
Healthy and productive individuals and families for filariasis-free Philippines

-Tacastacas
Mission
Elimination of Filariasis as public health problem thru a comprehensive approach and universal access to
quality health services

Objective
• To sustain transmission interruption in provinces through strengthening of surveillance
• To intensify interventions and interrupt transmission in persistent infection provinces
• To strengthen Morbidity Management & Disability Prevention (MMDP) activities and services to alleviate
suffering among chronic patients
• To strengthen the health system capacity to secure LF elimination
• Secure adequate investment from governmental and non-governmental sources to sustain all program
objective
Partner Institution
• University of the Philippines Manila- College of Public Health

• Glaxosmith Klein thru WHO

• USAID thru RTI ENVISION

Policies and Laws

• Administrative Order No. 24s.1998: Elimination of the disease
• Executive Order No. 369, 2004: Filariasis Mass Treatment Month
• World Health Assembly No. 50.29: Filariasis Elimination as public health problem
 • Formula One for Health: Disease-Free Zones
• KP Roadmap 2014-2016
• Sustainable Development Goal No. 3: Good Health and Well being
• Philippine Health Development Agenda: Disease for Elimination

Strategies, Action Points, and Timeline

1. Mass Drug Administration
2. Disability Management
3. Monitoring thru Midterm Sentinel surveys and Evaluation thru Transmission Assessment Survey
4. Post Validation Surveillance
5. Private-Public Partnership
Program Accomplishments/Status
Provinces have reached elimination level and declared as Filariasis-free as of 2017: 38 Provinces
Types of Services
Trainings
• Morbidity Management and Disability Prevention due to Lymphatic Filariasis (LF)
• Orientation on Dossier Preparation for LF Elimination online course
• Orientation on Transmission Assessment Survey
• Orientation on Filariasis Test Strip
• Orientation of Post Validation Surveillance

Partner Organizations
National/Government
CHED
International Partners

• World Health Organization

• USAID through Research Triangle Institute
MALARIA CONTROL
• Malaria is a life-threatening disease caused by plasmodium parasites
transmitted by anopheles mosquito or rarely through blood transfusion
and sharing of contaminated needles
Malaria Control And Elimination
Program by DOH
VISION
A Malaria–Free Philippines by 2030

MISSION
Further accelerate malaria control and transition towards elimination
Objectives
• Objective 1 (Universal Access) – To ensure universal access to reliable
diagnosis, highly effective and appropriate treatment and preventive measures
• Objective 2 (Governance and Human Resources) – To strengthen
governance and human resources capacity at all levels to manage and
implement malaria interventions
• Objective 3 (Health Financing) – To secure government and non-government
financing to sustain malaria control and elimination efforts at all levels
• Objective 4 (Health Information and Regulation) – To ensure quality malaria
services, timely detection of infection and immediate response, and information
and evidence to guide malaria elimination
PROGRAM COMPONENTS
1. Program Management and Health System
2. Diagnosis and Treatment
3. Vector Control
4. Advocacy and Social Mobilization
5. Surveillance, Outbreak Preparedness and Response
6. Monitoring and Evaluation
7. Partnerships
8. Assessment of Other Factors - assessment of the possible contribution of
factors such as government health expenditure, poverty, forest cover, etc
PARTNER INSTITUTIONS
• Filipinas Shell Foundation Inc. (PSFI)
• Asian Collaborative Training Network for Malaria (ACT Malaria)
• National Commission on Indigenous Peoples (NCIP)
• Bureau of Quarantine (BOQ)
• University of the Philippines-Philippine General Hospital (UP-PGH)
• Research Institute for Tropical Medicine (RITM)
• Asia Pacific Malaria Elimination Network (APMEN)
STRATEGIES, ACTION POINTS, AND
TIMELINE
• Early Detection and Prompt Treatment through • LLIN as continued cornerstone of vector
a strengthened case-finding mode; control
• Foci investigation and Classification as a • IRS in border areas and as outbreak
means to determine need for interventions; response mechanism;
• Annual Stratification using Foci Classification; • Quality assurance monitoring to cover all
aspects of malaria service delivery;
• Strengthened recording and reporting;
• Structured capability-building of local health
• Use of Primaquine as a transmission-blocking system staff; and
agent;
• Adaption of specified IEC strategies and
• Use of Artesunate ampoules and other social mobilization approaches for
suppositories; identified risk groups
• Expanded RDT and sustained microscopy
services;
PROGRAM ACCOMPLISHMENTS
/STATUS
• SUB-NATIONAL INITIATIVES WITH 42 PROVINCES DECLARED MALARIA -
FREE OUT OF 81 PROVINCES, ONLY 7 PROVINCES REMAINS WITH LOCAL
TRANSMISSION
• SIGNIFICANT REDUCTION OF CASES AND DEATHS THAT in 2010; 19,217
cases were detected with 33 deaths and a downward trend leading to 3,998
cases with 4 deaths in 2017. These figures denote 83% decrease in cases from
2010 to 2017
CALENDAR OF ACTIVITIES
• World Malaria Day, 25 April 2018
• Entomology Meeting, 16-17 May 2018
• Malaria Technical Working Group Meeting (quarterly or as need arises)
• OLMIS Meeting, 5 June 2018
• Entomology Refresher Course 23-28 July 2018
• Curriculum Refinement Workshop, 30 July to 3 Aug 2018
• Philippine Coordinating Committee Meeting (monthly)
• Mindanao Cluster Meeting (Cluster I, 8-9 August 2018; Cluster II, 28-29 August 2018)
• Integrated Vector Management Control, 13-17 August 2018
•External Competency Assessment 13-17 August 2018
POLICIES AND LAWS
● 1966 : Republic Act 4832: Malaria Eradication Law; an act creating the malaria
eradication service and providing funds for the duration of the campaign.
● 1973 : cut-off from the support of USAID and WHO
● 1982 : EO 851, ordered the decentralization and integration of malaria control in “the
general health sevices”
● 1983 : “Malaria Eradication” to “Malaria control”
● 1986 : EO 119 : change in the bureaucracy of the Philippine government – revising the
system of the Department of Health
● 1987 : Department Circular No. 167 s. 1987: Semi-vertical Malaria programme1991: RA
7160 “Local Government Code”
● 2009 : AO 2009-0001 “Revised Policy and Guidelines on the Diagnosis and Treatment of Malaria
● 2009:AO 2009-0024 “Reconstitution of the Country Coordinating Mechanism in Support of
the Global Fund to Fight Against AIDS, Tuberculosis and Malaria Grants in the Philippines”
● 2012: AO 2012-0026 “Guidelines in the Conduct of Border Operation”
● 2013: AO 2013-0007 “Guidelines on Establishment of Elimination Hub”
● 2013: AO 2013-0023 “Guidelines on Establishment of Collaborating Centers”
● 2014: AO 2014-0004: PhilMIS : Reporting and Recording of malaria cases
Reference:
https://doh.gov.ph/malaria-control-program
https://caro.doh.gov.ph/wp-content/uploads/2014/09/malaria.jpg
https://doh.gov.ph/malaria-control-program
Emerging/Re emerging
Infectious Diseases
B Y: C H R I S T I A N N E S E T H Y B A N E Z
Description
In the recent past, the Philippines has seen many outbreaks of emerging infectious diseases and
it continues to be susceptible to the threat of re-emerging infections such as leptospirosis, dengue,
meningococcemia, tuberculosis among. The current situation emphasizes the risks and highlights
the need to improve preparedness at local, national and international levels for against future
pandemics. New pathogens will continue to emerge and spread across regions and will challenge
public health as never before signifying grim repercussions and health burden. These may cause
countless morbidities and mortalities, disrupting trade and negatively affect the economy.

Emerging and Re-emerging Infectious Diseases are unpredictable and create a gap between
planning and concrete action. To address this gap, there is a need to come up with proactive
systems that would ensure preparedness and response in anticipation to negative consequences
that may result in pandemic proportions of diseases. Proactive and multi- disciplinary
preparedness must be in place to reduce the impact of the public the health threats.
Vision
A health system that is resilient, capable to prevent, detect and respond to the public health threats caused
by emerging and re-emerging infectious diseases
Mission
Provide and strengthen an integrated, responsive, and collaborative health system on emerging and re-
emerging infectious diseases towards a healthy and bio-secure country.
Goal
Prevention and control of emerging and re-emerging infectious disease from becoming public health
problems, as indicated by EREID case fatality rate of less than one percent
PROGRAM STRATEGIES:
The EREID Strategies are:
•Policy Development
•Resource Management and Mobilization
•Coordinated Networks of Facilities
•Building Health Human Resource Capacity
•Establishment of Logistics Management System
•Managing Information to Enhance Disease Surveillance
•Improving Risk Communication and Advocacy
Target Population/ Client
All ages; Citizen of the Philippines
Area of Coverage
Philippines and it’s international borders
Partner Institutions
DOH Central and Regional Bureau’s/Offices, Other Government and Non-Government Offices,
Medical Societies, Academe, Developmental Partners (World Health Organization, FAO-OIE, CDC,
GPP-Canada)
Policies and Laws
•Executive Order No. 168  -    Creating the Inter-Agency Task Force for the Management of Emerging
Infectious Diseases in the Philippines
•Administrative Order No. 10 s. 2011 - Creating the Philippine Inter-Agency Committee on Zoonosis,
Defining Its Powers, Functions, Responsibilities, Other Related Matters and Providing Funds Thereof
RABIES PREVENTION
AND CONTROL
PROGRAM
B Y: C H R I S T I A N N E S E T H Y B A N E Z
RABIES PREVENTION AND
CONTROL PROGRAM
Description:
Rabies is an infection that affects humans usually transmitted by a bite or scratch of an infected
animal. This is considered a significant public health problem in the country as it is one of the
most acutely fatal infections and responsible for the death of at least 200 Filipinos annually.
Effective and safe vaccines to prevent the disease in humans and animals have been available
for decades. However, its elimination is hampered by poverty and ignorance about the disease
and its prevention. Hence, this program aims to prevent and control rabies infection by
providing and promoting accessible vaccines, along with rabies education and awareness, to the
public.
VISION
 To declare Philippines Rabies-Free by year 2022

MISSION
 To eliminate human rabies by the year 2020

OBJECTIVES
 To eliminate rabies as a public health problem with absences of indigenous cases for
human and  animal
TYPES OF SERVICES
PhilHealth Benefit Package
PhilHealth for Animal Bite Package (Rabies Post-exposure Prophylaxis)

Trainings
Training Course on Rabies and Animal Bite Management
Outputs Expected/Competency Gained
INTEGRATED HELMNITH CONTROL
PROGRAM
ONTROL PROGRAM
Soil-transmitted Helminthiasis (STH), caused by common roundworms, whipworms, and hookworms,
remains a public health concern in the Philippines. Considered among the neglected tropical diseases
(NTDs) or infectious diseases of poverty, STH are related to poor physical health, nutritional status, and
school performance in children.
Disease burden of STH in the country among vulnerable and high-risk groups is quite high and way
above the global standard of less than 20% Cumulative Prevalence (CP). As such, this program aims to
reduce the Cumulative Prevalence of STH to less than 20% and Prevalence of Moderate to Heavy
Intensity Infection (MHII) to less than 2%.

-Aquino
Vision
STH-Free Philippines

Mission
Synchronized and harmonized public-private stakeholders’ effort in the control of Soil-
transmitted Helminthiasis (STH) in the Philippines.
Policies and Laws
Administrative Order No. 30-F s.1999 (Implementation of STH Control Program)
Administrative Order No. 2006-0028 (IHCP Operational and Strategic Framework)

Goals
Elimination of Soil-Transmitted Helminthiasis as a Public Health Program in Pre-school Children
(PSAC) and School Age Children (SAC) by 2022
(Prevalence of Moderate to Heavy Intensity Infection (MHII) of less than 2% in PSAC and SAC).
Comprehensive Packages
• Harmonized Schedule and Combined Mass Drug Administration (HSCMDA) for the month of January and July in
health centers, stations and schools.
• Diagnosis and selective treatment in health centers
• Provision of safe drinking water, basic sanitation and hygiene (WASH) in schools and community
• Health promotion and hygiene education
Partner Organizations:
National/Government
• Department of Education (DepEd)
• Department of Interior and Local Government (DILG)  
• Public Information Agency (PIA)
• Kapisanan ng mga Broadkaster ng Pilipinas (KBP)
Local/Youth/CSOs/NGOs

• Local Government Units (LGUs)

• Vitamin Angels
International Partners

• Research Triangle Institute (RTI) International

• World Health Organization (WHO)
• Save the Children
• Plan International
-THE END-